Skip to main content

Table 2 Time horizon of NMA publications by clinical indication

From: A scoping review of network meta-analyses assessing the efficacy and safety of complementary and alternative medicine interventions

Condition studied

Distribution of reports by year of publication

2010

2011

2012

2013

2014

2015

2016

2017

2018

Total

Acute promyelocytic leukemia

      

1

  

1

Attention deficit hyperactivity disorder

       

1

 

1

Alzheimer’s disease

       

1

1

2

Antibiotic-associated diarrhea

       

1

 

1

Atrophic vaginitis

        

1

1

Blood pressure reduction

       

1

 

1

Bulemia nervosa

        

1

1

Cancer-related fatigue

        

1

1

Cerebral infarction

        

1

1

Chronic ankle instability

        

1

1

Chronic fatigue syndrome

       

1

 

1

Chronic kidney disease

      

1

  

1

Chronic kidney disease mineral and bone disorder

       

1

 

1

Chronic low back pain

   

1

     

1

Chronic obstructive pulmonary disease

      

1

  

1

Chronic oro-facial pain

       

1

 

1

Chronic pain

     

1

   

1

Chronic prostatitis and chronic pelvic pain syndrome

 

1

1

   

1

  

3

Cognitive aging

     

1

   

1

Crohn's disease recurrence

       

1

 

1

Depression

      

1

  

1

Depressive disorders

     

1

   

1

Diabetic neuropathy

    

1

  

1

 

2

Exposure to domestic violence

      

1

  

1

Fibromyalgia syndrome (FMS)

   

1

     

1

Functional dyspepsia

       

1

 

1

Gastric cancer

    

1

   

1

2

Gastrointestinal cancer

       

2

 

2

Helicobacter pylori infection

       

3

 

3

Hepatic encephalopathy

     

1

   

1

Idiopathic pulmonary fibrosis

     

1

1

  

2

Infantile rotavirus enteritis

  

1

      

1

Insomnia

        

1

1

Interstitial cystitis/painful bladder syndrome

       

1

 

1

Kashin-Beck disease

        

1

1

Lateral epicondylalgia

      

1

  

1

Macular degeneration

        

1

1

Major depressive disorder

     

1

   

1

Menopausal symptoms

     

1

   

1

Myofacial pain syndrome

       

1

 

1

Necrotizing enterocolitis

       

1

 

1

Neurotoxicity from chemotherapy

       

1

 

1

Non-alcoholic fatty liver disease

      

1

  

1

Non-small cell lung cancer

      

1

  

1

Obsessive-compulsive disorder

      

1

  

1

Osteoarthritis (hip or knee)

1

  

1

 

2

 

2

1

7

Painful diabetic peripheral neuropathy

   

1

     

1

Pancreatic cancer

       

1

 

1

Panic disorder

      

1

  

1

Persistent depressive disorder

    

1

    

1

Post-natal depression

      

1

  

1

Post-operative complications

       

1

 

1

Post-stroke recovery

       

1

 

1

Preeclampsia and gestational hypertension

       

1

 

1

Pressure ulcers

       

1

 

1

Pre-term birth measures*

        

1

1

Preventing oxaliplatin-induced peripheral neurotoxicity

       

1

 

1

Prevention of advanced metachronous neoplasia

      

1

  

1

Prevention of respiratory tract infection

       

1

 

1

Prevention of type 2 diabetes in patients with prediabetes

        

1

1

Psoriasis

       

1

 

1

Psychologic preparation for surgery under general anesthesia

        

1

1

Psychotic disorders

     

1

  

1

2

Post-traumatic stress disorder

    

1

    

1

Rheumatoid arthritis

      

1

  

1

Sciatica

     

1

   

1

Shoulder impingement syndrome

     

1

   

1

Spasticity in multiple sclerosis

        

1

1

Stable angina

        

1

1

Stimulation of breast milk production

        

1

1

Stress urinary incontinence

1

        

1

Stroke prevention

     

1

   

1

Vasomotor symptoms

       

1

 

1

  1. A display of both year-by-year evolution of CAM-related NMAs by indication as well as the total number of NMAs per indication is provided. Numbers reported within individual cells refer to the # of NMAs in a calendar year.
  2. *mortality, necrotizing enterocolitis, late-onset sepsis, time to full enteral feed